Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Devices Deals, 2012 to YTD 2018 10
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 12
Applied Genetic Technologies Raises US$0.8 Million In Venture Financing 14
Partnerships 15
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 15
Applied Genetic Technologies Enters into Co-Development Agreement with BCM Families Foundation 16
Applied Genetic Technologies Enters into R&D Agreement with Synpromics 17
Licensing Agreements 18
Biogen Enters into Licensing Agreement with Applied Genetic Technologies 18
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 20
Equity Offering 21
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 21
Applied Genetic Tech Raises USD30 Million in Private Placement of Shares 23
Applied Genetic Completes Underwriters Exercise of Over-Allotment Option for Public Offering of Shares for USD34.5 Million 25
Applied Genetic Technologies Completes IPO For US$57.5 Million 27
Applied Genetic Technologies Corp – Key Competitors 29
Applied Genetic Technologies Corp – Key Employees 30
Applied Genetic Technologies Corp – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Sep 10, 2018: AGTC announces financial results and business update for the fourth quarter and fiscal year ended June 30, 2018 32
May 08, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018 34
Feb 09, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017 36
Nov 07, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017 38
Sep 13, 2017: AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 40
May 10, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 42
Feb 08, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 45
Corporate Communications 47
Sep 24, 2018: AGTC names William Aliski to its board of directors 47
Feb 14, 2018: AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors 48
Sep 05, 2017: AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer 49
Aug 02, 2017: AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel 50
Product News 51
06/08/2017: AGTC Announces Topline Safety Data for X-Linked Retinoschisis Phase 1/2 Study 51
05/09/2017: AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis at the Association for Research in Vision and Ophthalmology Annual Meeting 52
04/18/2018: AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa 53
Product Approvals 54
Aug 10, 2017: AGTC Files Investigational New Drug Application for the Treatment of X-linked Retinitis Pigmentosa Caused by Mutations in the RPGR Gene 54
Aug 03, 2017: AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa 55
Clinical Trials 56
Aug 07, 2017: Research Published in Molecular Therapy Identifies Optimal Gene-based Therapeutic Construct for X-Linked Retinitis Pigmentosa 56
Other Significant Developments 58
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Devices Deals, 2012 to YTD 2018 10
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 12
Applied Genetic Technologies Raises US$0.8 Million In Venture Financing 14
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 15
Applied Genetic Technologies Enters into Co-Development Agreement with BCM Families Foundation 16
Applied Genetic Technologies Enters into R&D Agreement with Synpromics 17
Biogen Enters into Licensing Agreement with Applied Genetic Technologies 18
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 20
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 21
Applied Genetic Tech Raises USD30 Million in Private Placement of Shares 23
Applied Genetic Completes Underwriters Exercise of Over-Allotment Option for Public Offering of Shares for USD34.5 Million 25
Applied Genetic Technologies Completes IPO For US$57.5 Million 27
Applied Genetic Technologies Corp, Key Competitors 29
Applied Genetic Technologies Corp, Key Employees 30
List of Figures
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Devices Deals, 2012 to YTD 2018 10